We spoke with Rebecca Edelmayer, PhD, the Alzheimer’s Association Senior Director of Scientific Engagement, about studies presented at the Alzheimer’s Association International Conference (AAIC) 2022 regarding individual’s life experiences and brain health.
Researchers sought to assess whether handgrip strength was associated with a higher risk for dementia, poorer neuroimaging outcomes, and a decline in cognitive function in men and women.
An earlier study identified several modifiable risk factors for dementia. As the number of people living with dementia has grown, researchers decided an updated analysis was needed regarding the connection between these risk factors and dementia.
In a randomized clinical trial, researchers determined the safety and efficacy of semorinemab, a monoclonal anti-tai antibody, in prodromal to mild AD.
Researchers sought to assess the independent associations of social isolation and loneliness with the likelihood of developing dementia and to explore the potential neurobiological mechanisms.
